Genetics
Inaugural Jack Sarver Prizes Awarded to St. Louis and Dallas Researchers for Cardiovascular Disease Prevention Studies
Two scientists from Washington University and UT Southwestern received the first Jack Sarver Prizes for research addressing maternal mortality in Nigeria through aspirin prophylaxis and identifying genetic mechanisms linking liver disease to atherosclerosis.
China's High-Oil Peanut Varieties Show Promise but Face Breeding Challenges
A comprehensive study of 238 high-oil peanut varieties in China reveals promising oil content up to 61% but identifies critical trade-offs between oil and protein content and limited disease resistance, providing crucial insights for future breeding strategies to enhance global peanut production.
Circular DNA Fragments Identified as Key Factor in Glioblastoma Lethality
International researchers have discovered that rogue circular DNA fragments operating independently from chromosomes may explain why glioblastoma remains so deadly despite medical advances, potentially opening new treatment pathways.
New Genetic Discovery Enhances Cancer Immunotherapy Potential
A groundbreaking genetic discovery could significantly improve the effectiveness of cancer immunotherapy, offering new hope for patients with certain types of cancer.
Genetic Breakthrough Could Personalize Brain Tumor Treatment
Researchers at the University of Kentucky have discovered a genetic biomarker that could help predict which glioblastoma patients may benefit from the drug bevacizumab, offering a new avenue for personalized cancer treatment.
Community Health Centers Expand Screening for Cardiovascular Disease Marker Lp(a)
The American Heart Association's initiative to screen for lipoprotein(a) in community health centers aims to reduce cardiovascular disease risk by identifying inherited risk factors early.
UC Davis Study Uncovers Genetic Mutation Affecting Immunotherapy Response in Solid Tumors
A study by UC Davis scientists reveals a genetic mutation that may explain why solid tumors are unresponsive to immunotherapy, potentially leading to more effective cancer treatments.
Tevard Biosciences Appoints Dr. Elisabeth Gardiner as Chief Scientific Officer to Advance tRNA-Based Therapies
Tevard Biosciences has appointed Dr. Elisabeth Gardiner as its new Chief Scientific Officer, marking a significant step in advancing its tRNA-based therapies for genetic diseases, with implications for treating conditions like Duchenne Muscular Dystrophy and TTN-related dilated cardiomyopathy.
Alfa Cytology Launches PARP Inhibitors Development Services for Advanced Cancer Treatment
Alfa Cytology has introduced comprehensive development services for PARP inhibitors, offering a promising avenue for more precise and personalized cancer treatments, particularly for cancers with genetic mutations like BRCA1 and BRCA2.
RNAi Pioneer Phillip Zamore Joins TransCode Therapeutics' Scientific Advisory Board
TransCode Therapeutics has added renowned RNA biology expert Dr. Phillip D. Zamore to its Scientific Advisory Board, potentially strengthening the company's RNA-targeted cancer therapy research and development strategy.
Tevard's tRNA Therapy Offers Promising Approach to Duchenne Muscular Dystrophy Treatment
Tevard Biosciences demonstrated a breakthrough in treating Duchenne Muscular Dystrophy by restoring full-length dystrophin protein using suppressor tRNA therapy, potentially offering hope for patients with nonsense mutations.
Study Reveals Pregnancy-Related Genes Contribute to Worse Lung Cancer Outcomes in Women
A new study from Memorial Sloan Kettering Cancer Center has uncovered how certain genes associated with pregnancy may negatively impact lung cancer survival rates in women, providing insights into potential future immune therapy developments.
Geneticist Urges Bold Climate Action with Innovative CO2 Removal Strategies
Dr. David E. Comings calls on U.S. leaders to address the accelerating climate crisis by implementing scientifically-driven carbon removal technologies. His research highlights the urgent need for immediate intervention to reverse environmental damage.
Tevard Advances Promising tRNA Therapy for Duchenne Muscular Dystrophy
Tevard Biosciences reports breakthrough preclinical data demonstrating a novel suppressor tRNA therapy that successfully restored dystrophin protein and motor function in a Duchenne muscular dystrophy model, potentially offering hope for patients with nonsense mutations.
Study Links Shorter Telomeres to Higher Risk of Age-Related Brain Diseases
New research involving 356,000 UK participants reveals that shorter telomeres, markers of biological aging, are associated with increased risk of stroke, dementia, and late-life depression. The findings highlight the potential role of lifestyle choices in mitigating health risks associated with cellular aging.